Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Longitudinal Within-Patient Evaluation of the Effectiveness (Durability) of Carticel® (Autologous Cultured Chondrocytes) Compared to Non-Carticel Surgical Treatment for Articular Cartilage Defects of the Knee.

NCT00158613 is registered in ClinicalTrials.gov with Vericel Corporation as lead sponsor.

NCT NCT00158613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00158613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Longitudinal Within-Patient Evaluation of the Effectiveness (Durability) of Carticel® (Autologous Cultured Chondrocytes) Compared to Non-Carticel Surgical Treatment for Articular Cartilage Defects of the Knee.
Lead sponsor
Vericel Corporation
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2000
Completion date
November 30, 2005
Enrollment
126 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

articular cartilage